nutrients-logo

Journal Browser

Journal Browser

Nutritional Regulation of Lipid Metabolism and Health

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Nutrition and Metabolism".

Deadline for manuscript submissions: closed (15 August 2021) | Viewed by 23644

Special Issue Editor


E-Mail Website
Guest Editor
UMR 1280 Physiopathologie des Adaptations Nutritionnelles (PhAN), INRAE, Université de Nantes 44 093 Nantes, France
Interests: cardiovascular disease; lipid metabolism; isotopic labelling and modelling analysis

Special Issue Information

Dear Colleagues,

Lipids are highly diverse in structure, and their distribution varies at the organism level.

In recent years, by using multiplex platforms, emerging lipidomic techniques allow for the high-throughput profiling of thousands of lipids categorized into five main species—namely, glycerolipids, phospholipids, sphingolipids, cholesterols, and free fatty acids.

The disturbance of lipids homeostasis is the major mechanism which promotes, directly or indirectly, several diseases. To take CVD as an example, plasma lipid biomarkers including high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein cholesterol (LDL-c), and triglycerides have long been used to assess the risk and treatment of CVD. However, using more recent lipidomic approaches, other lipids at very low concentrations in the blood (particularly some sphingolipids or phosphides) were found to have a strong positive association with recurrent CVD and CVD mortality, independent of HDL-c and LDL-c, and are key bioactive signaling elements in the body. The use of diverse and complementary approaches such as biochemistry, molecular biology, genetics, and physiology provides a good understanding of the mechanisms involved in these chronic diseases.

There is tremendous interest in the health protection of some food constituents against chronic diseases in which elevated lipids and inflammation are major issues. Overall, a lower disease risk for food groups of plant origin has been found, whereas a higher disease risk for sugar-sweetened beverages and certain food groups of animal origin has been identified. Thus, the nutritional regulation of lipid metabolism has become an important tool to prevent or reverse the development of chronic diseases. This nutritional intervention can take place at different stages of life, including the perinatal stage.

Dr. Khadija Ouguerram
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lipids
  • glycerolipids
  • phospholipids
  • sphingolipids
  • cholesterols
  • free fatty acids
  • metabolism
  • disease

Published Papers (7 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

22 pages, 1767 KiB  
Article
Impact of Fatty Acid Supplementation on Cognitive Performance among United States (US) Military Officers: The Ranger Resilience and Improved Performance on Phospholipid-Bound Omega-3’s (RRIPP-3) Study
by Bernadette P. Marriott, Travis H. Turner, Joseph R. Hibbeln, Jill C. Newman, Marcie Pregulman, Angela M. Malek, Robert J. Malcolm, Gregory A. Burbelo and Jeffrey W. Wismann
Nutrients 2021, 13(6), 1854; https://0-doi-org.brum.beds.ac.uk/10.3390/nu13061854 - 29 May 2021
Cited by 11 | Viewed by 3697
Abstract
Studies have assessed omega-3 fatty acids and cognitive decline among older adults and cognitive development among children, although less is known about cognitive or neurological effects among young adults. We examined whether omega-3 supplementation from krill oil could improve cognition and resilience among [...] Read more.
Studies have assessed omega-3 fatty acids and cognitive decline among older adults and cognitive development among children, although less is known about cognitive or neurological effects among young adults. We examined whether omega-3 supplementation from krill oil could improve cognition and resilience among young military officers compared to a control. This double-blind, placebo-controlled trial enrolled 555 officers (mean age 23.4 ± 2.8, 98.6% male) entering the United States (US) Army Infantry Basic Officer Leaders Course (IBOLC) with the intention to complete the US Ranger Course. Volunteer participants consumed eight dietary supplements daily of krill oil containing 2.3 g omega-3 or control (macadamia nut oil) over an approximate 20-week period. Cognitive functioning, resilience, and mood were assessed during a well-rested period at approximately 14 weeks and after a battlefield simulation at 16 weeks. Blood spot samples were collected to monitor compliance and dietary intake was assessed. All hypotheses were tested using both ‘Intention to Treat’ (ITT) and ‘As Per Protocol’ (APP) approaches. Of the 555 randomized individuals, 245 (44.1%) completed the study. No statistically significant group-by-time interactions indicating treatment effect were found on any outcomes. Poor compliance was indicated by lower than expected omega-3 elevations in the treatment group, and may have contributed to a failure to detect a response. Full article
(This article belongs to the Special Issue Nutritional Regulation of Lipid Metabolism and Health)
Show Figures

Figure 1

15 pages, 3104 KiB  
Article
Hepatic Transcriptome Profiling Reveals Lack of Acsm3 Expression in Polydactylous Rats with High-Fat Diet-Induced Hypertriglyceridemia and Visceral Fat Accumulation
by Kristýna Junková, Lukáš F. Mirchi, Blanka Chylíková, Michaela Janků, Jan Šilhavý, Martina Hüttl, Irena Marková, Denisa Miklánková, Josef Včelák, Hana Malínská, Michal Pravenec, Ondřej Šeda and František Liška
Nutrients 2021, 13(5), 1462; https://0-doi-org.brum.beds.ac.uk/10.3390/nu13051462 - 25 Apr 2021
Cited by 6 | Viewed by 2782
Abstract
Metabolic syndrome (MetS) is an important cause of worldwide morbidity and mortality. Its complex pathogenesis includes, on the one hand, sedentary lifestyle and high caloric intake, and, on the other hand, there is a clear genetic predisposition. PD (Polydactylous rat) is an animal [...] Read more.
Metabolic syndrome (MetS) is an important cause of worldwide morbidity and mortality. Its complex pathogenesis includes, on the one hand, sedentary lifestyle and high caloric intake, and, on the other hand, there is a clear genetic predisposition. PD (Polydactylous rat) is an animal model of hypertriglyceridemia, insulin resistance, and obesity. To unravel the genetic and pathophysiologic background of this phenotype, we compared morphometric and metabolic parameters as well as liver transcriptomes among PD, spontaneously hypertensive rat, and Brown Norway (BN) strains fed a high-fat diet (HFD). After 4 weeks of HFD, PD rats displayed marked hypertriglyceridemia but without the expected hepatic steatosis. Moreover, the PD strain showed significant weight gain, including increased weight of retroperitoneal and epididymal fat pads, and impaired glucose tolerance. In the liver transcriptome, we found 5480 differentially expressed genes, which were enriched for pathways involved in fatty acid beta and omega oxidation, glucocorticoid metabolism, oxidative stress, complement activation, triacylglycerol and lipid droplets synthesis, focal adhesion, prostaglandin synthesis, interferon signaling, and tricarboxylic acid cycle pathways. Interestingly, the PD strain, contrary to SHR and BN rats, did not express the Acsm3 (acyl-CoA synthetase medium-chain family member 3) gene in the liver. Together, these results suggest disturbances in fatty acid utilization as a molecular mechanism predisposing PD rats to hypertriglyceridemia and fat accumulation. Full article
(This article belongs to the Special Issue Nutritional Regulation of Lipid Metabolism and Health)
Show Figures

Figure 1

17 pages, 9932 KiB  
Article
Urinary Medium-Chained Acyl-Carnitines Sign High Caloric Intake whereas Short-Chained Acyl-Carnitines Sign High -Protein Diet within a High-Fat, Hypercaloric Diet in a Randomized Crossover Design Dietary Trial
by Nadezda V. Khodorova, Annemarie Rietman, Douglas N. Rutledge, Jessica Schwarz, Julien Piedcoq, Serge Pilard, Els Siebelink, Frans J. Kok, Daniel Tomé, Marco Mensink and Dalila Azzout-Marniche
Nutrients 2021, 13(4), 1191; https://0-doi-org.brum.beds.ac.uk/10.3390/nu13041191 - 03 Apr 2021
Cited by 3 | Viewed by 2510
Abstract
The western dietary pattern is known for its frequent meals rich in saturated fat and protein, resulting in a postprandial state for a large part of the day. Therefore, our aim was to investigate the postprandial glucose and lipid metabolism in response to [...] Read more.
The western dietary pattern is known for its frequent meals rich in saturated fat and protein, resulting in a postprandial state for a large part of the day. Therefore, our aim was to investigate the postprandial glucose and lipid metabolism in response to high (HP) or normal (NP) protein, high-fat hypercaloric diet and to identify early biomarkers of protein intake and hepatic lipid accumulation. In a crossover design, 17 healthy subjects were randomly assigned to consume a HP or NP hypercaloric diet for two weeks. In parallel, a control group (CD; n = 10) consumed a weight-maintaining control diet. Biomarkers of postprandial lipid and glucose metabolism were measured in 24 h urine and in plasma before and following a meal challenge. The metabolic profile of urine but not plasma, showed increased excretion of 13C, carnitine and short chain acyl-carnitines after adaptation to the HP diet. Urinary excretion of decatrienoylcarnitine and octenoylcarnitine increased after adaptation to the NP diet. Our results suggest that the higher excretion of short-chain urinary acyl-carnitines could facilitate the elimination of excess fat of the HP diet and thereby reduce hepatic fat accumulation previously reported, whereas the higher excretion medium-chains acyl-carnitine could be early biomarkers of hepatic lipid accumulation. Full article
(This article belongs to the Special Issue Nutritional Regulation of Lipid Metabolism and Health)
Show Figures

Graphical abstract

14 pages, 2945 KiB  
Article
Carrot Supplementation Improves Blood Pressure and Reduces Aortic Root Lesions in an Atherosclerosis-Prone Genetic Mouse Model
by Raffaella Soleti, Marine Coué, Charlotte Trenteseaux, Gregory Hilairet, Lionel Fizanne, Fatima Kasbi-Chadli, Patricia Mallegol, Julien Chaigneau, Jerome Boursier, Michel Krempf, Emmanuel Geoffriau, Ramaroson Andriantsitohaina and Khadija Ouguerram
Nutrients 2021, 13(4), 1181; https://0-doi-org.brum.beds.ac.uk/10.3390/nu13041181 - 02 Apr 2021
Cited by 5 | Viewed by 3445
Abstract
Epidemiological studies have shown that carrot consumption may be associated with a lower risk of developing several metabolic dysfunctions. Our group previously determined that the Bolero (Bo) carrot variety exhibited vascular and hepatic tropism using cellular models of cardiometabolic diseases. The present study [...] Read more.
Epidemiological studies have shown that carrot consumption may be associated with a lower risk of developing several metabolic dysfunctions. Our group previously determined that the Bolero (Bo) carrot variety exhibited vascular and hepatic tropism using cellular models of cardiometabolic diseases. The present study evaluated the potential metabolic and cardiovascular protective effect of Bo, grown under two conditions (standard and biotic stress conditions (BoBS)), in apolipoprotein E-knockout (ApoE−/−) mice fed with high fat diet (HFD). Effects on metabolic/hemodynamic parameters and on atherosclerotic lesions have been assessed. Both Bo and BoBS decreased plasma triglyceride and expression levels of genes implicated in hepatic de novo lipogenesis and lipid oxidation. BoBS supplementation decreased body weight gain, secretion of very-low-density lipoprotein, and increased cecal propionate content. Interestingly, Bo and BoBS supplementation improved hemodynamic parameters by decreasing systolic, diastolic, and mean blood pressure. Moreover, Bo improved cardiac output. Finally, Bo and BoBS substantially reduced the aortic root lesion area. These results showed that Bo and BoBS enriched diets corrected most of the metabolic and cardiovascular disorders in an atherosclerosis-prone genetic mouse model and may therefore represent an interesting nutritional approach for the prevention of cardiovascular diseases. Full article
(This article belongs to the Special Issue Nutritional Regulation of Lipid Metabolism and Health)
Show Figures

Graphical abstract

11 pages, 587 KiB  
Article
Associations between Circulating Markers of Cholesterol Homeostasis and Macrovascular Events among Patients Undergoing Hemodialysis
by Wen-Chin Lee, Wei-Hung Kuo, Sin-Hua Moi, Barry Chiu, Jin-Bor Chen and Cheng-Hong Yang
Nutrients 2021, 13(3), 1014; https://0-doi-org.brum.beds.ac.uk/10.3390/nu13031014 - 21 Mar 2021
Cited by 2 | Viewed by 2674
Abstract
Current strategies targeting serum cholesterol bring limited benefits to mortality and macrovascular events prevention among hemodialysis patients. Direct measurements and analysis on circulating markers of cholesterol homeostasis could be promising solutions to this bottleneck. We prospectively enrolled 90 maintenance hemodialysis patients and 9 [...] Read more.
Current strategies targeting serum cholesterol bring limited benefits to mortality and macrovascular events prevention among hemodialysis patients. Direct measurements and analysis on circulating markers of cholesterol homeostasis could be promising solutions to this bottleneck. We prospectively enrolled 90 maintenance hemodialysis patients and 9 healthy controls in 2019 for 1 year. We measured circulating desmosterol and lathosterol as markers for cholesterol synthesis and campesterol and sitosterol for cholesterol absorption. At baseline, hemodialysis patients showed higher levels of campesterol (p = 0.023) compared to healthy controls. During follow-up, we identified 14 (15.4%) patients who experienced macrovascular events. Comparisons of cholesterol homeostasis markers between cohorts with and without macrovascular events showed no significant differences in markers of cholesterol synthesis or absorption. Using logistic regression analysis, the odds ratio was not statistically significant for the prediction of macrovascular events after full-adjusting for age, sex, diabetes, serum albumin, cholesterol, and triglyceride. We concluded that hemodialysis patients demonstrated higher level of cholesterols absorption, indicated by circulating campesterol compared to healthy subjects. Markers for cholesterol homeostasis were not significantly associated with macrovascular events during a 1-year follow-up. Our results shed light on the novel therapeutic target of modulating cholesterol absorption in HD patients. Full article
(This article belongs to the Special Issue Nutritional Regulation of Lipid Metabolism and Health)
Show Figures

Figure 1

17 pages, 2418 KiB  
Article
The Marine Microalga, Tisochrysis lutea, Protects against Metabolic Disorders Associated with Metabolic Syndrome and Obesity
by Claire Mayer, Léo Richard, Martine Côme, Lionel Ulmann, Hassan Nazih, Benoît Chénais, Khadija Ouguerram and Virginie Mimouni
Nutrients 2021, 13(2), 430; https://0-doi-org.brum.beds.ac.uk/10.3390/nu13020430 - 28 Jan 2021
Cited by 14 | Viewed by 3047
Abstract
Long-chain polyunsaturated fatty acids n-3 series and especially docosahexaenoic acid are known to exert preventive effects on metabolic disturbances associated with obesity and decrease cardiovascular disease risk. n-3 LC-PUFAs are mainly consumed in the form of fish oil, while other sources, such as [...] Read more.
Long-chain polyunsaturated fatty acids n-3 series and especially docosahexaenoic acid are known to exert preventive effects on metabolic disturbances associated with obesity and decrease cardiovascular disease risk. n-3 LC-PUFAs are mainly consumed in the form of fish oil, while other sources, such as certain microalgae, may contain a high content of these fatty acids. The aim of this study was to evaluate the effects of Tisochrysis lutea (Tiso), a microalga rich in DHA, on metabolic disorders associated with obesity. Three male Wistar rat groups were submitted for eight weeks to a standard diet or high-fat and high fructose diet (HF), supplemented or not with 12% of T. lutea (HF-Tiso). The supplementation did not affect plasma alanine aminotransferase (ALAT). Bodyweight, glycemia and insulinemia decreased in HF-Tiso rats (ANOVA, p < 0.001), while total plasma cholesterol, high-density lipoprotein-cholesterol (HDL-C) increased (ANOVA, p < 0.001) without change of low-density lipoprotein-cholesterol (LDL-C) and triacylglycerol (TAG) levels. Tiso supplementation decreased fat mass and leptinemia as well as liver TAG, cholesterol and plasma tumor necrosis factor-alpha levels (ANOVA, p < 0.001) while it did not affect interleukin 6 (IL-6), IL-4 and lipopolysaccharides levels. HF-Tiso rats showed an increase of IL-10 level in abdominal adipose tissue (ANOVA, p < 0.001). In conclusion, these results indicated that DHA-rich T. lutea might be beneficial for the prevention of obesity and improvement of lipid and glucose metabolism. Full article
(This article belongs to the Special Issue Nutritional Regulation of Lipid Metabolism and Health)
Show Figures

Figure 1

Review

Jump to: Research

18 pages, 2028 KiB  
Review
The Effect of Walnut Intake on Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by Saeed Mastour Alshahrani, Reham M. Mashat, Diaa Almutairi, Alaa Mathkour, Sahar Saad Alqahtani, Amirah Alasmari, Abdullah Hassan Alzahrani, Reem Ayed, Mohammed Yahya Asiri, Alsanussi Elsherif and Abdullah Alsabaani
Nutrients 2022, 14(21), 4460; https://0-doi-org.brum.beds.ac.uk/10.3390/nu14214460 - 23 Oct 2022
Cited by 6 | Viewed by 3949
Abstract
Cardiovascular diseases (CVD) are the leading causes of death worldwide. Dyslipidemia is a cardiometabolic risk factor of CVD, yet it can be modifiable. Walnuts have been suggested as a dietary intervention to improve the lipid profile. Therefore, we reviewed the literature to assess [...] Read more.
Cardiovascular diseases (CVD) are the leading causes of death worldwide. Dyslipidemia is a cardiometabolic risk factor of CVD, yet it can be modifiable. Walnuts have been suggested as a dietary intervention to improve the lipid profile. Therefore, we reviewed the literature to assess the evidence linking walnut intake to the improvement of blood lipids, including total cholesterol (TC), low-density lipoprotein (LDL-C) cholesterol, high-density lipoprotein (HDL-C) cholesterol, and triglycerides (TG). PubMed and Embase databases were searched from 2010 up to March 2022. We limited our search to randomized controlled trials conducted on humans and published in English during the specified period. Cochrane’s risk of bias tool for interventional studies was used. A random-effects model was used for the meta-analysis, and weighted mean differences were obtained (WMD) Thirteen trials from the U.S., Europe, and Asia were included. Walnut intake was associated with significant reductions in TC (WMD: −8.58 mg/dL), LDL-C (WMD: −5.68 mg/dL), and TG (WMD: −10.94 mg/dL). Walnut consumption was not associated with HDL-C. Subgroup analysis showed that overweight/obese and those with comorbidities had more lipid improvement. A longer trial duration did result in further improvements. However, our results may be prone to bias due to extraneous confounding factors. Additionally, levels of heterogeneity were considerable for some outcomes of interest. Results from this meta-analysis provide evidence for the health benefits of walnuts on blood lipids. Walnuts possibly reduce the risk of CVD; thus, they can be successfully added to a dietary pattern to enhance health benefits. Full article
(This article belongs to the Special Issue Nutritional Regulation of Lipid Metabolism and Health)
Show Figures

Figure 1

Back to TopTop